Chloé Melchior1, Guillaume Gourcerol2, Pierre Déchelotte3, Anne-Marie Leroi2, Philippe Ducrotté1. 1. Gastroenterology Department, Rouen University Hospital, Rouen, France ; INSERM UMR-1073, Rouen University Hospital, Rouen, France. 2. INSERM UMR-1073, Rouen University Hospital, Rouen, France ; Physiology Department, Rouen University Hospital, Rouen, France. 3. INSERM UMR-1073, Rouen University Hospital, Rouen, France ; Nutrition Unit, Rouen University Hospital, Rouen, France.
Abstract
INTRODUCTION: Fructose can trigger or worsen symptoms in irritable bowel syndrome (IBS) patients. The aim of this study was to determine the prevalence of symptomatic fructose malabsorption in IBS patients and to test whether the patient's characteristics can help to detect a fructose malabsorption. MATERIALS AND METHODS: Ninety Rome III IBS patients (predominant diarrhoea (IBS-D): 31%, predominant constipation (IBS-C): 18%, mixed type (IBS-M): 51%) were included prospectively. After exclusion of a small intestinal bacterial overgrowth by a glucose breath test, fructose malabsorption was assessed by a five-hour breath test, with symptom monitoring, after a 25 g load of fructose. An increase of more than 20 ppm of hydrogen (H2) or methane (CH4) levels in the exhaled air led to the diagnosis of malabsorption. RESULTS: Fructose test was abnormal in 20/90 patients among whom only 35% were intolerant, with a simultaneous rise of H2/CH4 levels and the onset of abdominal discomfort or diarrhoea. IBS characteristics were not predictive even if young (p = 0.031) and male IBS patients (p = 0.029) were at higher risk of malabsorption. At variance, 18 additional patients experienced intestinal symptoms during the test despite normal fructose absorption. DISCUSSION: After a 25 g fructose load, symptomatic fructose malabsorption and intolerance without malabsorption were detected in 22% and 28% of IBS patients respectively.
INTRODUCTION:Fructose can trigger or worsen symptoms in irritable bowel syndrome (IBS) patients. The aim of this study was to determine the prevalence of symptomatic fructose malabsorption in IBSpatients and to test whether the patient's characteristics can help to detect a fructose malabsorption. MATERIALS AND METHODS: Ninety Rome III IBSpatients (predominant diarrhoea (IBS-D): 31%, predominant constipation (IBS-C): 18%, mixed type (IBS-M): 51%) were included prospectively. After exclusion of a small intestinal bacterial overgrowth by a glucose breath test, fructose malabsorption was assessed by a five-hour breath test, with symptom monitoring, after a 25 g load of fructose. An increase of more than 20 ppm of hydrogen (H2) or methane (CH4) levels in the exhaled air led to the diagnosis of malabsorption. RESULTS:Fructose test was abnormal in 20/90 patients among whom only 35% were intolerant, with a simultaneous rise of H2/CH4 levels and the onset of abdominal discomfort or diarrhoea. IBS characteristics were not predictive even if young (p = 0.031) and male IBSpatients (p = 0.029) were at higher risk of malabsorption. At variance, 18 additional patients experienced intestinal symptoms during the test despite normal fructose absorption. DISCUSSION: After a 25 g fructose load, symptomatic fructose malabsorption and intolerance without malabsorption were detected in 22% and 28% of IBSpatients respectively.
Authors: G Nucera; M Gabrielli; A Lupascu; E C Lauritano; A Santoliquido; F Cremonini; G Cammarota; P Tondi; P Pola; G Gasbarrini; A Gasbarrini Journal: Aliment Pharmacol Ther Date: 2005-06-01 Impact factor: 8.171
Authors: Jianfeng Yang; Yanyong Deng; Hua Chu; Yanqun Cong; Jianmin Zhao; Daniel Pohl; Benjamin Misselwitz; Michael Fried; Ning Dai; Mark Fox Journal: Clin Gastroenterol Hepatol Date: 2012-12-13 Impact factor: 11.382
Authors: Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller Journal: Nat Rev Dis Primers Date: 2016-03-24 Impact factor: 52.329
Authors: Leah R Villegas; Christopher J Rivard; Brandi Hunter; Zhiying You; Carlos Roncal; Melanie S Joy; MyPhuong T Le Journal: PLoS One Date: 2018-11-08 Impact factor: 3.240